{"00001": "What effects calcium physical properties mucus CF patients", "00002": "Can one distinguish effects mucus hypersecretion infection submucosal glands respiratory tract CF", "00003": "How salivary glycoproteins CF patients different normal subjects", "00004": "What lipid composition CF respiratory secretions", "00005": "Is CF mucus abnormal", "00006": "What effect water therapeutic agents physical properties viscosity elasticity sputum bronchial secretions CF patients", "00007": "Are mucus glycoproteins degraded differently CF patients compared normal subjects", "00008": "What histochemical differences described normal CF respiratory epithelia", "00009": "What association liver disease cirrhosis vitamin A metabolism CF", "00010": "What role Vitamin E therapy patients CF", "00011": "What difference meconium ileus meconium plug syndrome", "00012": "What abnormalities amino acid transport described small bowel CF patients", "00013": "What clinical biochemical features pancreatitis CF patients", "00014": "What noninvasive tests performed evaluation exocrine pancreatic function patients CF", "00015": "What hepatic complications manifestations CF", "00016": "What gastrointestinal complications CF neonatal period exclude liver disease meconium ileus", "00017": "What effective regimen use pancreatic enzyme supplements treatment CF patients", "00018": "Is dietary supplementation bile salts therapeutic benefit CF patients", "00019": "What complications pancreatic enzyme therapy reported CF patients", "00020": "What effect treatment CF patients essential fatty acid supplements", "00021": "Does pancreatic insufficiency CF patients affect ability absorb metabolize iron", "00022": "What frequency CF nonCaucasian populations", "00023": "What congenital hereditary diseases conditions found association CF", "00024": "What characteristics patients CF incompletely manifested", "00025": "What evidence genetic basis CF involves one gene", "00026": "What heterozygote advantage CF", "00027": "What concordance clinical biochemical manifestations CF sibling pairs CF", "00028": "What incidence male fertility CF", "00029": "What pathology reproductive system male female CF", "00030": "What results genetic counseling families children CF", "00031": "What major psychological social effects CF patients families", "00032": "What factors influence compliance prescribed therapy CF patients", "00033": "What conditions factors lead erroneous sweat tests", "00034": "What alternative techniques classical GibsonCooke quantitative pilocarpine iontophoresis test titrimetric analysis chloride available sweat testing relative advantages disadvantages", "00035": "Has CF patient found consistently normal sweat tests", "00036": "What concentration potassium sweat CF patients", "00037": "What techniques available screening newborn infants CF factors contribute erroneous results tests", "00038": "Can CF diagnosed prenatally", "00039": "How may heterozygotes CF identified", "00040": "Other sweat test techniques may useful beyond neonatal period diagnosis CF", "00041": "Is Vitamin D metabolism normal CF patients", "00042": "What abnormalities insulin secretion insulin metabolism occur CF patients", "00043": "Is salt sodium andor chloride transportpermeability abnormal CF", "00044": "What structural enzymatic differences fibroblasts CF patients nonCF patients", "00045": "What abnormalities prostaglandin metabolism described CF patients", "00046": "What properties activity galactosyltransferase enzymes CF patients", "00047": "What differences normal subjects CF patients described function metabolism hormones", "00048": "Do fibroblasts CF patients grow normal rate", "00049": "Is RNA methylation polyamine metabolism normal CF patients", "00050": "What defects synthesis metabolism cyclic nucleotides described CF patients", "00051": "What circulating secreted factors described CF patients Factors unidentified biologically active molecules thought play pathogenetic role cystic fibrosis", "00052": "What known prolactin CF patients", "00053": "Does secretory IgA protect CF patients bacterial colonization infection", "00054": "What relationship allergy hypersensitivity lung disease CF patients", "00055": "What interactions proteases endogenous bacterial origin antiproteases lungs CF patients", "00056": "What relationship nutrition pulmonary host defenses bacterial infection CF patients", "00057": "What pathophysiologic role circulating antibodies Pseudomonas aeruginosa CF patients", "00058": "What immunologic response pulmonary infection CF patients", "00059": "What immunologic abnormalities found CF patients", "00060": "What effects CF pulmonary circulation", "00061": "Is defect mucociliary transport clearance respiratory tract CF patients", "00062": "What clinical features lung disease CF patients", "00063": "What biochemical microscopic characteristics airway inflammation CF patients", "00064": "How lung function change time CF patients time periods greater day", "00065": "What abnormalities pulmonary function CF patients", "00066": "What pathologic features lung disease CF patients", "00067": "What prognosis patients episode respiratory failure", "00068": "What effects bronchodilators CF patients", "00069": "What best way treat pneumothorax CF patients", "00070": "What treatment prognosis hemoptysis CF patients", "00071": "What prognosis infants wheezing cystic fibrosis", "00072": "What best treatment nasal polyps CF patients", "00073": "How effective bronchial lavage CF patients", "00074": "What results mechanical ventilation CF patients respiratory failure", "00075": "What best treatment pulmonary hypertension andor cor pulmonale CF patients", "00076": "What effects exercise training programs lung function CF patients", "00077": "What techniques effective promoting clearance mucus lungs CF patients", "00078": "What special considerations treatment CF patients antibiotics ie pharmacodynamics antibiotics different CF patients special problems peculiar CF", "00079": "What role orally administered antibiotics treatment CF patients", "00080": "What evidence combination therapy aminoglycosides semisynthetic penicillins effective therapy either alone", "00081": "How effective inhalations mucolytic agents treatment CF patients", "00082": "What role aerosols treatment lung disease CF patients", "00083": "What role bacterial phagocytosis alveolar macrophages polymorphonuclear leukocytes lung disease CF patients", "00084": "What relationship Haemophilus influenzae Pseudomonas aeruginosa CF patients", "00085": "Do CF patients ever develop infection organs lung If organs", "00086": "What role bacteria Pseudomonas aeruginosa Staphylococcus aureus Haemophilus influenzae pathogenesis lung disease CF patients", "00087": "What role fungi pathogenesis lung disease CF patients", "00088": "What role viral infection lung disease CF patients", "00089": "What epidemiology Pseudomonas aeruginosa CF patients Specifically CF patients spread Pseudomonas aeruginosa patients individuals family", "00090": "What factors responsible appearance mucoid strains Pseudomonas aeruginosa CF patients", "00091": "What unusual manifestations CF lung disease exocrine pancreatic insufficiency", "00092": "What prognosis survival patients CF", "00093": "Do CF patients normal intelligence", "00094": "What animal models available relevant CF", "00095": "What abnormalities skeletal muscle function structure found CF patients", "00096": "Is increased incidence dental problems eg caries periodontal disease CF patients", "00097": "Is oxygen transport red blood cells abnormal CF patients", "00098": "What effects CF development andor function brain central nervous system", "00099": "Are abnormalities taste CF patients", "00100": "What incidence treatment hypertrophic osteoarthropathy CF patients"}